Â鶹ŮÓÅ

The third human case of H5N1, reported on Thursday in a farmworker in Michigan who was experiencing respiratory symptoms, tells us that the current bird flu situation is at a dangerous inflection point. (Rick Bright, 6/2)

Artificial wombs are moving from the realm of science fiction to possible trials with severely premature human babies. We are excited about the great potential benefits of this technology; however, with fetal rights now a political front in the abortion debate, we believe that society must address the ethical and legal implications well before those clinical trials begin. (Vardit Ravitsky and Louise King, 5/31)

In today’s labor market, good help is hard to find. For companies developing antibiotics, it’s becoming nearly impossible. Three years ago, I became CEO of the AMR Action Fund, which is investing approximately $1 billion in biotech companies developing treatments for antimicrobial-resistant infections, a growing global health crisis that now contributes to 4.9 million deaths every year. I have spent most of my career developing antibiotics and investing in biotechnology companies, so I was aware of the scientific and financial headwinds we’d be up against — including workforce challenges. (Henry Skinner, 6/3)

On Monday, Dr. Anthony Fauci will return to the halls of Congress to testify before the House subcommittee investigating the Covid-19 pandemic. He will most likely be questioned about how the National Institute of Allergy and Infectious Diseases, which he directed until retiring in 2022, supported risky virus work at a Chinese institute whose research may have caused the pandemic. (Alina Chan, 6/2)

Anecdotes aren’t data (as the apparently oft-misquoted saying goes), but over the past 14 years the two paint a depressingly similar picture of Britain’s National Health Service. (Therese Raphael, 6/2)